25.7 C
New York
Wednesday, June 17, 2026

Tag: Johnson

Transocean Ltd. Provides Quarterly Fleet Status Report

STEINHAUSEN, Switzerland, July 16, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) today issued a quarterly Fleet Status Report that provides the current status of, and contract information for, the company’s fleet of offshore drilling rigs.

NeoVolta Predicts Third Consecutive Record Quarter; Forecasts Over 225% Revenue Growth for Fiscal Year 2025

Another NeoVolta record quarter; projects 225%+ FY25 growth, expanding rapidly in U.S. energy storage market.

Steve Madden Announces Second Quarter 2025 Earnings Release Date

LONG ISLAND CITY, N.Y., July 16, 2025 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (NASDAQ: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced that the Company plans to release its second quarter 2025 earnings results on Wednesday, July 30, 2025. Management will host a conference call to review the results at 8:30 a.m. Eastern Time.

Loftware Awarded SAP Spotlight+ Partner Status, Recognized as Leading Labeling Solution for SAP Customers

Recognition highlights Loftware's role in driving intelligent supply chain transformation with SAP PORTSMOUTH, N.H., July 16, 2025  /PRNewswire/ -- Loftware, a global leader in product...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Menin Inhibitors Market Forecasts Signal Strong Uptake of Menin Inhibitors in Hematologic Oncology Across the 7MM During the Forecast Period (2020-2034) | DelveInsight

The menin inhibitor market is poised for rapid growth, with REVUFORJ setting the foundation and a strong pipeline of innovative, genetically targeted therapies on...

Gain Therapeutics Announces Proposed Public Offering

BETHESDA, Md., July 15, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase common stock in an underwritten public offering. Gain expects to grant the underwriter a 30-day option to purchase up to an additional 15% of the shares of common stock and/or the warrants offered in the offering. All of the securities are being offered by the Company.

OtterBox Unveils Summer’s Must-Have Threads with New Cactus Leather Embroidery Cases

FORT COLLINS, Colo., July 15, 2025 /PRNewswire/ -- Embrace summer's must-have threads with the latest drop from OtterBox – the Cactus Leather Embroidery Collection. Combining...

St. Cloud State University Launches Online Business Programs to Serve Minnesota’s Communities and Workforce

ST. CLOUD, Minn., July 15, 2025 /PRNewswire/ -- St. Cloud State University is introducing five new online business degree programs in Fall 2025 to...

PXG Congratulates Gina Kim on Stellar Victory at Hartford HealthCare Women’s Championship

Rising star dominates the field to earn her third Epson Tour title of the season
Rising star dominates the field to earn her third Epson Tour title of the season

Transocean Ltd. Announces Second Quarter 2025 Earnings Release Date

STEINHAUSEN, Switzerland, July 14, 2025 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the second quarter 2025 on Monday, August 4, 2025. The company will conduct a teleconference starting at 9 a.m. EDT, 3 p.m. CEST, on Tuesday, August 5, 2025.

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 15, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 14, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

LABCONNECT APPOINTS MITCHELL BLUMENFELD AS CHIEF FINANCIAL OFFICER

JOHNSON CITY, Tenn., July 14, 2025 /PRNewswire/ -- LabConnect is pleased to announce the appointment of Mitch Blumenfeld as its Chief Financial Officer, effective August...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsJohnson